These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1031 related items for PubMed ID: 10773235

  • 1. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
    Peterson JT, Li H, Dillon L, Bryant JW.
    Cardiovasc Res; 2000 May; 46(2):307-15. PubMed ID: 10773235
    [Abstract] [Full Text] [Related]

  • 2. MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition.
    Li H, Simon H, Bocan TM, Peterson JT.
    Cardiovasc Res; 2000 May; 46(2):298-306. PubMed ID: 10773234
    [Abstract] [Full Text] [Related]

  • 3. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
    Kossakowska AE, Edwards DR, Lee SS, Urbanski LS, Stabbler AL, Zhang CL, Phillips BW, Zhang Y, Urbanski SJ.
    Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Effects of doxycycline on the expression of matrix metalloproteinase and tissue inhibitor of MMP in myocardium after acute myocardial infarction: an animal experiment with rats].
    Zhang P, Yang YJ, Chen X, Ruan YM, Zhou YW, Tian Y, Chen ZJ.
    Zhonghua Yi Xue Za Zhi; 2004 Aug 02; 84(15):1288-93. PubMed ID: 15387968
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy.
    Thomas CV, Coker ML, Zellner JL, Handy JR, Crumbley AJ, Spinale FG.
    Circulation; 1998 May 05; 97(17):1708-15. PubMed ID: 9591765
    [Abstract] [Full Text] [Related]

  • 9. Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat.
    Knittel T, Mehde M, Grundmann A, Saile B, Scharf JG, Ramadori G.
    Histochem Cell Biol; 2000 Jun 05; 113(6):443-53. PubMed ID: 10933221
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
    Zhang X, Sakamoto T, Hata Y, Kubota T, Hisatomi T, Murata T, Ishibashi T, Inomata H.
    Exp Eye Res; 2002 May 05; 74(5):577-84. PubMed ID: 12076079
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Amlodipine and Atorvastatin Improved Hypertensive Cardiac Remodeling through Regulation of MMPs/TIMPs in SHR Rats.
    Lu J, Hao J, Du H, Xiao B, Li Y, Yang X, Cui W.
    Cell Physiol Biochem; 2016 May 05; 39(1):47-60. PubMed ID: 27322513
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis.
    Papakonstantinou E, Dionyssopoulos A, Aletras AJ, Pesintzaki C, Minas A, Karakiulakis G.
    J Am Acad Dermatol; 2004 Oct 05; 51(4):526-33. PubMed ID: 15389186
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dynamic changes in the expression of matrix metalloproteinases and their inhibitors, TIMPs, during hepatic fibrosis induced by alcohol in rats.
    Xu GF, Li PT, Wang XY, Jia X, Tian DL, Jiang LD, Yang JX.
    World J Gastroenterol; 2004 Dec 15; 10(24):3621-7. PubMed ID: 15534918
    [Abstract] [Full Text] [Related]

  • 20. Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy.
    Tyagi SC, Kumar SG, Haas SJ, Reddy HK, Voelker DJ, Hayden MR, Demmy TL, Schmaltz RA, Curtis JJ.
    J Mol Cell Cardiol; 1996 Jul 15; 28(7):1415-28. PubMed ID: 8841929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.